1Nagler RM,Hershkovich O. Silochemical and gustatory ananlysis in patients with oral sensorial complaints [J]. The Jounal of Pain, 2004, 5 (1) : 56-63.
2Granot M,Nagler RM. Association between regional idiopathic neu- ropathy and salivary involvement as the possible mechanism for oral sensory complaints [J]. The Jounal of Pain, 2005,, 6 (9) : 581-587.
3Makoto T, Yuki N,Tomoko T, et al. Oral complaints and stimulated salivary flow rate in 1188 adults [J]. J Oral Pathol Med, 2010, 39(5) : 407-419.
4Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment [J]. J Am Dent Assoc, 2003, 134 (1) : 61-69.
5Valdez IH,Fox PC. Diagnosis and management of salivary dysfunc- tion [J]. Crit Rev Oral Biol Med, 1993,4(3-4) : 271-277.
6Suh KI, Lee JY, Chung JW, et al. Relationship between salivary flow rate and clinical symptoms and behaviours in patients with dry mouth [J]. J Oral Rehabil, 2007, 34 (10) : 739-744.
7Billings RJ,Proskin HM,Moss ME. Xerostomia and associated fac- tors in a a community-dwelling adult population [J]. Community Dent Oral Epidemiol, 1996, 24 (5) : 312-316.
8Nagler RM,Nagler A. Pilocarpine Hydrochloride relieves xerostomia in chronic graft vs host disease: A sialometrical study [J]. Bone Mar- row Transplant, 1999, 23 (10) : 1007-1011.
9Spielman AL. Chemosensory function and dysfunction [.J]. Crit Rev Oral Biol Med, 1998,9 (3) : 267-291.
10Matsuo R, Yamamoto T. Effects of inorganic constituents of saliva on taste response of the rat chorda tympani nerve [J]. Brain Res, 1992, 583 (1-2) : 71-80.
二级参考文献6
1Tarkkila L, Linna M, Tiitinen A et al. Oral symptoms at menopause - the of hormone replacement therapy. Oral Surg Oral Patrol Oral Radiol Endod, 2001, 92 (3): 276.
2Tanak M, Toyooka E, Kohno Set al. Long - term changes in orbicular structure of aged rat alveolar bone after ovariectomy. OralSurg Oral Patrol Oral Radiol Endod , 2003, 95 (4) : 495.
3Tankka M, Ejiri S, Toyeoka E, et al. Effects of ovariectomy on trabeculat- estructures of rat alveolar bone. J Periodontal Res, 2002, 37 ( 1 ) : 161.
4Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal resuits from the women' s health initiative randomized controlled triaal. J Am Med Assoc, 2002, 288 (3) : 321.
5Morise AP. Assessment of estrogen statusas a marker of prognosis in women with symptoms of suspected coronary artery disease presenting for stress testing. Am J Cardiol, 2006, 97 (3) : 367.
